| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |